Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
Asterias Biotherapeutics, Inc. (AST) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/08/2019 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of Asterias Biotherapeutics, Inc",
"Amended and Restated Bylaws of Asterias Biotherapeutics, Inc"
03/01/2019 8-K Quarterly results
11/08/2018 8-K Acquisition/merger/asset purchase announced
Docs: "AGREEMENT AND PLAN OF MERGER",
"Amended and Restated Employment Agreement, by and between Asterias Biotherapeutics, Inc. and Craig Halberstadt",
"Amended and Restated Employment Agreement, by and between Asterias Biotherapeutics, Inc. and Edward Wirth, III",
"Amended and Restated Employment Agreement, by and between Asterias Biotherapeutics, Inc. and Ryan Chavez",
"BioTime Acquires Two Clinical-Stage Cell Therapy Product Candidates Addressing Significant Unmet Needs in Spinal Cord Injury and Immuno-Oncology Asterias Stockholders to Receive 0.71 Shares of BioTime for Each Share of Asterias Biotherapeutics ALAMEDA, CA and FREMONT, CA – - BioTime, Inc. , and Asterias Biotherapeutics, Inc. , today announced that they have entered into a definitive merger agreement whereby BioTime will acquire all of the remaining outstanding common stock of Asterias that are not currently owned by BioTime. Asterias stockholders will receive 0.71 shares of BioTime common shares for every share of Asterias common stock and will own approximately 16.2% of the combined company. Subject to customary closing conditions, including approval by the respective shareholders of BioT..."
10/01/2018 8-K Quarterly results
09/18/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/25/2018 8-K Submission of Matters to a Vote of Security Holders
12/05/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/16/2017 8-K Quarterly results
10/02/2017 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Asterias Announces Two Significant Developments for Spinal Cord Injury Program",
"PowerPoint Presentation, October 2017"
09/26/2017 8-K Quarterly results
09/07/2017 8-K Quarterly results
08/17/2017 8-K Quarterly results
06/16/2017 8-K Form 8-K - Current report
05/23/2017 8-K Form 8-K - Current report
05/15/2017 8-K Form 8-K - Current report
02/03/2017 8-K Form 8-K - Current report
01/24/2017 8-K Form 8-K - Current report
11/17/2016 8-K Form 8-K - Current report
11/17/2016 8-K Form 8-K - Current report
11/16/2016 8-K Form 8-K - Current report
10/20/2016 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "PowerPoint Presentation"
10/12/2016 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "PowerPoint Presentation"
09/19/2016 8-K Material Modifications to Rights of Security Holders, Financial Statements and Exhibits
Docs: "Amendment to the Warrant Agreement by and between the Company and American Stock Transfer & Trust Company"
09/12/2016 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "PowerPoint Presentation"
08/22/2016 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "PowerPoint Presentation"
08/17/2016 8-K Quarterly results, Conference call transcript
Docs: "FREMONT, Calif. – August 15, 2016 –",
"Transcript of conference call held on August 15, 2016"
08/09/2016 8-K Entry into a Material Definitive Agreement
06/14/2016 8-K Form 8-K - Current report
05/10/2016 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Underwriting Agreement, by and between the Company and Raymond James & Associates, Inc",
"Form of Warrant Agreement by and between the Company and American Stock Transfer & Trust Company, including the form of Warrant",
"Opinion of Dentons US LLP",
"Asterias Biotherapeutics Announces Proposed Public Offering",
"Asterias Biotherapeutics Prices Public Offering of Common Stock and Warrants"
04/29/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Howard I. Scher M.D., Leading Clinical Oncology Expert, Joins the Board of Directors of Asterias Biotherapeutics"
04/12/2016 8-K Form 8-K - Current report
04/05/2016 8-K Form 8-K - Current report
03/24/2016 8-K Form 8-K - Current report
03/16/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy